Related references
Note: Only part of the references are listed.Histone Deacetylase 7 Controls Endothelial Cell Growth Through Modulation of β-Catenin
Andriana Margariti et al.
CIRCULATION RESEARCH (2010)
Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis
Roel H. Wilting et al.
EMBO JOURNAL (2010)
Cyclin D1 Is a Bona Fide Target Gene of NFATc1 and Is Sufficient in the Mediation of Injury-induced Vascular Wall Remodeling
Manjula Karpurapu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells
Priyanka Sharma et al.
MOLECULAR CANCER (2010)
Deficiency of the NR4A Neuron-Derived Orphan Receptor-1 Attenuates Neointima Formation After Vascular Injury
Takashi Nomiyama et al.
CIRCULATION (2009)
Histone Deacetylase Inhibitors Current Status and Overview of Recent Clinical Trials
Xujun Ma et al.
DRUGS (2009)
Histone deacetylases modulate vascular smooth muscle cell migration induced by cyclic mechanical strain
Zhi-Qiang Yan et al.
JOURNAL OF BIOMECHANICS (2009)
Role of smooth muscle cells in the initiation and early progression of atherosclerosis
Amanda C. Doran et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis
Tao Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly
Fernando S. Santiago et al.
CIRCULATION RESEARCH (2007)
The mammalian epigenome
Bradley E. Bernstein et al.
CELL (2007)
The role of chromatin during transcription
Bing Li et al.
CELL (2007)
Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21WAF1
Hiroshi Okamoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2006)
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy
Yongli Kong et al.
CIRCULATION (2006)
Histone deacetylase inhibitors suppress the inducibility of nuclear factor-κB by tumor necrosis factor-α receptor-1 down-regulation
Gabriele Imre et al.
CANCER RESEARCH (2006)
Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo
OG McDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
被撤回的出版物: Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2 (Retracted article. See vol. 295, pg. 294, 2020)
K Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-κB/p65 DNA binding
J Hu et al.
MOLECULAR CANCER RESEARCH (2005)
Histone deacetylase inhibition-mediated post-translational elevation of p27(kip1) protein levels is required for G(1) arrest in fibroblasts
JS Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions
F Miao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA
KB Glaser et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A novel histone deacetylase inhibitor, Scriptaid, enhances expression of functional estrogen receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine
JC Keen et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Differential gene expression in vascular smooth muscle cells in primary atherosclerosis and in stent stenosis in humans
QJ Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
VJ Dzau et al.
NATURE MEDICINE (2002)
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
G Lagger et al.
EMBO JOURNAL (2002)
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
VM Richon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells
L Qiu et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Share Paper
